Number of the records: 1  

ustekinumab

  1. Subject h.ustekinumab
    Subject h.Ustekinumab
    Entry termsCNTO 1275
    CNTO-1275
    Scope note in EnglishA humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.
    Pharmacology effect dermatologiká
    Pharmacology effect Dermatologic Agents
    See also reference (FX) in Slovak interleukín-12
    interleukín-23
    See also reference (FX) in English Interleukin-12
    Interleukin-23
    Links (36) - ARTICLES
    (2) - MeSH descriptor
    (6) - CiBaMed
    (3) - ELECTRONIC RESOURCES
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.